These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35211868)

  • 1. Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination.
    Goodson JL; Rota PA
    Drug Deliv Transl Res; 2022 May; 12(5):959-967. PubMed ID: 35211868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.
    Richardson LC; Moss WJ
    Pan Afr Med J; 2020; 35(Suppl 1):3. PubMed ID: 32373254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priorities for global measles and rubella control and eradication.
    Goodson JL; Chu SY; Rota PA; Moss WJ; Featherstone DA; Vijayaraghavan M; Thompson KM; Martin R; Reef S; Strebel PM
    Vaccine; 2012 Jul; 30(32):4709-16. PubMed ID: 22549089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent setbacks in measles elimination: the importance of investing in innovations for immunizations.
    Goodson JL
    Pan Afr Med J; 2020; 35(Suppl 1):15. PubMed ID: 32373266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elimination of measles and rubella in Germany: Progress and hindrances].
    Pfaff G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1222-4. PubMed ID: 23990082
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Dhalaria P; Kumar P; Verma A; Priyadarshini P; Kumar Singh A; Tripathi B; Taneja G
    Vaccine; 2024 Jun; 42(17):3637-3646. PubMed ID: 38704248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
    Kretsinger K; Strebel P; Kezaala R; Goodson JL
    J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
    Soble A; Ko M; Gilchrist S; Malvolti S; Hasso-Agopsowicz M; Giersing B; Amorij JP; Jarrahian C; El Sheikh F; Menozzi-Arnaud M; Scarna T
    Vaccine; 2024 Feb; 42(6):1230-1246. PubMed ID: 38326130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Global Elimination Of Measles And Rubella With Strengthening Of Health Systems In Developing Countries.
    Andrus JK; Cochi SL; Cooper LZ; Klein JD
    Health Aff (Millwood); 2016 Feb; 35(2):327-33. PubMed ID: 26858388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination.
    Gastañaduy PA; Goodson JL; Panagiotakopoulos L; Rota PA; Orenstein WA; Patel M
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S420-S428. PubMed ID: 34590128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.
    Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP
    Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress Toward Measles and Rubella Elimination - Indonesia, 2013-2022.
    Chacko S; Kamal M; Hastuti EB; Mildya F; Kelyombar C; Voronika V; Yosephine P; Tandy G; Anisiska D; Karolina S; Dewi LA; Khanal S; Bahl S; Wijayanti F; Merrill RD; Hsu CH; Morales M
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(42):1134-1139. PubMed ID: 37856681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.